COVIRNA video: Can RNAs aid in predicting cardiovascular outcomes of COVID-19?
The COVIRNA Consortium is pleased to share the official COVIRNA video. The video outlines the aim of the COVIRNA project to generate an innovative diagnostic tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications in the context of the current pandemic, ultimately leading to their improved surveillance and care.
The COVIRNA project is a patient-centred Innovation Action bringing together 15 European partners to develop a tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications in the context of the current pandemic, with the goal of improving individualised surveillance, care, and follow-up of patients.
To achieve this goal, COVIRNA will build a biobank to perform a multi-centre international study using 2000 blood samples from existing COVID-19 patient cohorts. Following biomarker qualification, COVIRNA will identify a subset of highly specific, long, non-coding RNAs that are predictive of COVID-19 clinical outcome. Using the long, non-coding RNAs and clinical data collected, COVIRNA will build a disease evolution prediction model. This will set the stage for designing a reliable and cost-efficient diagnostic test to predict COVID-19 clinical outcomes.
The project will raise stakeholders’ awareness of the novel diagnostic solution as a tool for healthcare professionals and encourage sharing of practical knowledge to achieve the best healthcare outcomes.
The video was produced with the support of Science Animated.
Please join us in sharing this video widely.